COVID-19: WHO recommends Regeneron antibody therapy for high-risk & seronegative patients

What is the news?  Recently, World Health Organization (WHO) approved the Regeneron antibody combination for treatment of the novel coronavirus disease (COVID-19).  What is Regeneron?  Regeneron is a combination of two drugs — casirivimab and imdevimab.  It has reduced mortality in seronegative patients with severe infections. The drug cocktail replicates the natural antibody response of human beings. Last year it was approved by the… Continue reading COVID-19: WHO recommends Regeneron antibody therapy for high-risk & seronegative patients